Invention for Innovation - Product Development Awards Committee C

  • Published: 31 October 2023
  • Version: V3.0 June 2024
  • 3 min read

The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has five committees: three for Product Development Awards (committee A, committee B and committee C), one for Challenge Awards, and one for Connect.

Committee members - Product Development Awards Selection Committee C

Name Position Organisation Expertise

Ms Joanna Smart (Chair)

Investor Director

BGF

Ms Smart has been active in the life sciences sector for over 20 years, as a CEO, non-executive chair and board director with experience in operating roles in SMEs, startups, global biotech, and investment banking.

Mrs Sarah Biggs

Public Committee Member

PPI Representative

PPI Representative

Ms Jacqueline Birks

NIHR Senior Medical Statistician

 University of Oxford

Ms Birks is a medical statistician who has worked on large clinical trials in different clinical areas including neurology, mental health, surgery and dementia.

Professor Philip Breedon

Professor of Smart Technologies

Nottingham Trent University

Professor Breedon is a medical design engineer with interests in wearable and rehabilitation technologies, Extended Reality, AI, surgical and mobile robotics and the surgical pathway.

Professor Daniel Freeman

Professor of Clinical Psychology

University of Oxford

Professor Freeman is a clinical psychologist with experience in mental health, digital health apps, virtual reality and implementation. In 2016, he created the spin-out company Oxford VR.

Mr Sam Gray

Managing Partner

Apposite Capital

Mr Gray has more than 20 years of experience in healthcare investment with extensive expertise in digital health and medical products.

Dr Surbhi Gupta

Senior Regulatory Affairs Lead (Medical Devices)

NHS England

Dr Gupta is an experienced medtech executive specialised in progressing innovative healthcare assets towards regulatory approval and commercialisation.

Dr Stephen Hicks

Co-founder

OXSIGHT Ltd

Dr Hicks has expertise in the development and commercialisation of medical devices and software including: electronics, physiological monitoring, computer vision & AI. Diagnostics, therapies and assistive technologies for neurology, sensory
and motor difficulties.

Dr James Kinross

Reader in Colorectal Surgery and Consultant Surgeon

Imperial College London

Dr Kinross has expertise in robotic surgery and minimally
invasive surgery for colorectal cancer. He performs translational research
in the fields of the microbiome, early colorectal cancer detection and prevention and in surgical technology transfer.

Professor David Lowe

Clinical Director for health innovation

Chief Scientist Office

Professor Lowe is an emergency consultant with radiology, imaging, AI and healthcare innovation expertise.

Professor Roma Maguire

Professor of Digital Health and Care

University of Strathclyde

Professor Maguire has a clinical background as a nurse and has experience with digital health, developing apps, leading large clinical trials and implementation science.

Mr Stuart Mealing

Associate Director (Health Economics and Outcomes Research)

York Health Economics Consortium Ltd

Mr Mealing has experience in the development and review of cost-effectiveness and budget impact models and working with medical devices and the modelling of orphan/ultra-orphan conditions.

Professor Steve Morris

CEO

Ingram Networks Ltd

Professor Morris has experience in the development of medical devices from concept to regulatory approval and first human use.

Dr Kam Pooni

CEO

Glyconics Ltd

Dr Pooni has over 25 years of life sciences and MedTech commercialisation expertise, including regulatory, market entry and adoption routes.

Dr Krishan Ramdoo

CEO Tympa Health and NHS Clinical Entrepreneur Fellow.

Northwick Park Institute for Medical Research

Dr Ramdoo is an ear, nose and throat surgeon with experience in developing a product starting from a lab bench to commercial product.

Dr Matthew Reeves

Associate Professor/Reader in Molecular Virology

University College London

Dr Reeves has a specialty in infectious diseases focusing primarily on human cytomegalovirus latency and reactivation, and viral pathogenesis in human transplantation.

Ms Josephine Tapper

Public Committee Member

PPI  Representative

PPI  Representative

Professor Wendy Tindale OBE

Director

Sheffield Teaching Hospitals; NIHR Devices for Dignity MIC

Professor Tindale is a Consultant Medical Physicist and is experienced in collaborative MedTech development and NHS implementation.

Professor Yan Yiannakou

Clinical Consultant

County Durham and Darlington NHS Foundation Trust

Professor Yiannakou is a gastroenterologist by background and an innovator with strong clinical trial expertise. He has previously held posts as Director of R&D of an NHS Trust and Director of the NIHR Patient Recruitment Centre, Newcastle.